CHINA IN-TECH (00464) issued 56.7 million share options.
Chinese Intelligent Technology (00464) announced that on April 27, 2026, the company granted 56.7 million share options to 9 eligible individuals (grantees) under the share option plan adopted on August 22, 2025. The share options entitle the grantees to subscribe for a total of 56.7 million shares of the company's ordinary shares with a par value of HK$0.001 per share, but they must be accepted by the grantees before they can be exercised.
CHINA IN-TECH (00464) announced on April 27, 2026, that the company has granted 56.7 million warrants to 9 eligible individuals (grantees) under the stock purchase plan adopted on August 22, 2025, to subscribe for a total of 56.7 million shares of the company's common stock at a par value of HK$0.001 per share. However, the issuance can only be completed after acceptance by the grantees.
Related Articles
Zhou Hei Ya (01458) spent HKD 990,600 to repurchase 686,000 shares on April 27th.
In the first quarter, the net profit attributable to the parent company of Cig Shanghai (06166) was 118 million yuan, an increase of 276.44% year-on-year.
Guangzhou Baiyunshan Pharmaceutical Holdings (00874) reported a net profit attributable to shareholders of 1.784 billion yuan in the first quarter, a decrease of 2.06% year-on-year.
Zhou Hei Ya (01458) spent HKD 990,600 to repurchase 686,000 shares on April 27th.
In the first quarter, the net profit attributable to the parent company of Cig Shanghai (06166) was 118 million yuan, an increase of 276.44% year-on-year.
Guangzhou Baiyunshan Pharmaceutical Holdings (00874) reported a net profit attributable to shareholders of 1.784 billion yuan in the first quarter, a decrease of 2.06% year-on-year.
